4.5 Article

Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Diabetes, Metformin, and Breast Cancer in Postmenopausal Women

Rowan T. Chlebowski et al.

JOURNAL OF CLINICAL ONCOLOGY (2012)

Article Oncology

Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial

Bernardo Bonanni et al.

JOURNAL OF CLINICAL ONCOLOGY (2012)

Article Oncology

Clinically Defined Type 2 Diabetes Mellitus and Prognosis in Early-Stage Breast Cancer

Kirsten Erickson et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Article Oncology

Associations of Insulin Resistance and Adiponectin With Mortality in Women With Breast Cancer

Catherine Duggan et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Editorial Material Oncology

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

Mitch Dowsett et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)

Article Oncology

Metabolic profile, physical activity, and mortality in breast cancer patients

Aina Emaus et al.

BREAST CANCER RESEARCH AND TREATMENT (2010)

Article Oncology

Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells

Mahvash Zakikhani et al.

BREAST CANCER RESEARCH AND TREATMENT (2010)

Article Oncology

Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis

Andrea DeCensi et al.

CANCER PREVENTION RESEARCH (2010)

Article Oncology

Insulin-Lowering Effects of Metformin in Women with Early Breast Cancer

Pamela J. Goodwin et al.

CLINICAL BREAST CANCER (2008)

Article Gastroenterology & Hepatology

Metformin induces apoptosis of pancreatic cancer cells

Luo-Wei Wang et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2008)

Article Oncology

Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer

Anna Marie Mulligan et al.

BREAST CANCER RESEARCH AND TREATMENT (2007)

Article Oncology

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells

Mahvash Zakikhani et al.

CANCER RESEARCH (2006)